|
| Analyst
Scorecard | | Analyst: | Willey, Stephen | EPS
Est. Accuracy: | 
| | Broker: | Thomas Weisel Partners | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
|
| Not Avl.
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ALNY
|
Alnylam Pharmaceuticals Inc
|
|
9
| | | | |
ALXN
|
Alexion Pharmaceuticals Inc
| 
|
15
| | | | |
ANDS
|
Anadys Pharmaceuticals Inc
|
|
11
| | | | |
CBST
|
Cubist Pharmaceuticals Inc
|
|
12
| | | | |
ITMN
|
Intermune Inc.
|
|
12
| | | | |
ONXX
|
Onyx Pharmaceuticals Inc
|
|
13
| | | | |
OSIP
|
Osi Pharmaceuticals Inc
|
|
15
| | | | |
VPHM
|
Viropharma Inc
|
|
13
| | | |
| Other Stocks Covered
| |
Affymax Inc (AFFY), Amgen Inc (AMGN), Array Biopharma Inc (ARRY), Biogen Idec Incorporated (BIIB), Biomarin Pharmaceutical Inc (BMRN), Celgene Corporation (CELG), Genzyme Corp (GENZ), Gilead Sciences Inc (GILD), Human Genome Sciences Incorporat (HGSI), Idenix Pharmaceuticals Inc (IDIX), Neurocrine Biosciences Inc (NBIX), Rigel Pharmaceuticals (RIGL), Theravance Inc (THRX), Vical Incorporated (VICL), Vertex Pharmaceuticals Inc (VRTX)
|
| | |
|
|
|